Tag: Lung Cancer
-

Immunotherapy Advances in SCLC: Promise, Limitations, and Biomarker Needs
Overview: Immunotherapy’s Emerging Role in SCLC Small cell lung cancer (SCLC) has long challenged clinicians with its aggressive biology and tendency for rapid relapse. In recent years, immunotherapy has emerged as a beacon of hope, offering meaningful efficacy gains in several lines of treatment. This article reviews the current state of immunotherapy in SCLC, highlighting…
-

Why Lung Cancer Cases Are Rising Among Indian Women: Understanding the Risk and the Road Ahead
Unpacking the Rise in Lung Cancer Among Indian Women Lung cancer is not just a disease of men. In India, the burden among women is growing, driven by a complex mix of smoking patterns, environmental exposures, and limited access to early detection. Recent analyses of global cancer data show that Indian women face a higher…
-

Lung Cancer Rising Among Indian Women: Causes, Risks, and Prevention
Why Indian Women Face a Rising Risk of Lung Cancer Lung cancer among Indian women is an increasing public health concern. While historically perceived as a condition predominantly affecting men, evidence from global and national cancer registries shows that Indian women are experiencing higher lifetime risks than before. This shift is driven by a complex…
-

Why Lung Cancer is Rising Among Indian Women: Causes, Barriers, and Prevention
Why Lung Cancer Cases Are Rising Among Indian Women Lung cancer among Indian women is an emerging public health concern. While historically less common than in men, recent data show a worrying uptick in incidence and mortality. Understanding the drivers behind this trend is essential for policies, health messaging, and personal choices that can reduce…
-

Inflammation Drives Early Lung Cancer: MD Anderson Maps
New Insights into the Onset of Lung Cancer Researchers at The University of Texas MD Anderson Cancer Center have unveiled a landmark approach to understanding how lung cancer begins. By creating high-resolution cellular and molecular maps of lung tissue before and during cancer development, the team shows that chronic inflammation may be a primary driver…
-

Inflammation identified as a key driver in the earliest stages of lung cancer
New insights point to inflammation as a trigger in early lung cancer Researchers at The University of Texas MD Anderson Cancer Center have unveiled high-resolution cellular and molecular maps that illuminate how inflammation may initiate lung cancer in its earliest stages. The study, which charts the lung’s microenvironment before and during tumor development, suggests that…
-

Inflammation Drives Early Lung Cancer, MD Anderson Study Finds
Overview: Inflammation as an Early Driver of Lung Cancer A groundbreaking study by researchers at The University of Texas MD Anderson Cancer Center suggests that inflammation may be a crucial catalyst in the very first stages of lung cancer development. By assembling high-resolution cellular and molecular maps of lung tissue before and during tumor emergence,…
-

Dye Illuminates Lung Nodules for Early Cancer Detection
Understanding Lung Nodules and the Challenge of Early Detection Lung nodules are small, round growths in the lungs that show up on imaging tests like CT scans. While most nodules are benign, some can indicate early stages of lung cancer. Because nodules are often tiny—sometimes only a few millimeters across—spotting them early can be difficult.…


